Takada, H., Kurosaki, M., Tsuchiya, K., Komiyama, Y., Itakura, J., Takahashi, Y., . . . Izumi, N. (2019). Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular Carcinoma. Cancers (Basel).
शिकागो स्टाइल उद्धरणTakada, Hitomi, et al. "Baseline and Early Predictors of Good Patient Candidates for Second-Line After Sorafenib Treatment in Unresectable Hepatocellular Carcinoma." Cancers (Basel) 2019.
एमएलए उद्धरणTakada, Hitomi, et al. "Baseline and Early Predictors of Good Patient Candidates for Second-Line After Sorafenib Treatment in Unresectable Hepatocellular Carcinoma." Cancers (Basel) 2019.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.